Published in Kidney Int on August 01, 1992
Angiotensin II plays a pathogenic role in immune-mediated renal injury in mice. J Clin Invest (1999) 1.21
Urinary angiotensinogen accurately reflects intrarenal Renin-Angiotensin system activity. Am J Nephrol (2010) 1.13
Augmented intrarenal and urinary angiotensinogen in hypertension and chronic kidney disease. Pflugers Arch (2012) 0.99
Addition of angiotensin II type 1 receptor blocker to CCR2 antagonist markedly attenuates crescentic glomerulonephritis. Hypertension (2011) 0.91
Angiotensinogen Expression Is Enhanced in the Progression of Glomerular Disease. Int J Clin Med (2011) 0.84
Changes in urinary angiotensinogen posttreatment in pediatric IgA nephropathy patients. Pediatr Nephrol (2014) 0.75
The new angiotensin II receptor antagonist, irbesartan: pharmacokinetic and pharmacodynamic considerations. Am J Hypertens (1997) 0.89